Wouldn’t this be retail pharmacies raising the prices, not the mfr or distributor?
This could hurt Adderall long term as it could be shifting customers to other stimulants available today that feel that their perceived risk of drug being out of stock is mitigated.
News 
Market Data 
Discover 
